Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophagitis | 4 | 2021 | 152 | 1.940 |
Why?
|
Liver Neoplasms | 13 | 2022 | 4249 | 1.910 |
Why?
|
Hamartoma | 3 | 2022 | 234 | 1.720 |
Why?
|
Liver | 13 | 2022 | 7470 | 1.480 |
Why?
|
Choristoma | 3 | 2021 | 213 | 1.460 |
Why?
|
Hypertension, Portal | 3 | 2023 | 220 | 1.440 |
Why?
|
Adenoma, Liver Cell | 2 | 2020 | 33 | 1.430 |
Why?
|
Carcinoma, Hepatocellular | 9 | 2022 | 2211 | 1.390 |
Why?
|
Gastritis | 2 | 2019 | 191 | 1.140 |
Why?
|
Hepatitis, Autoimmune | 2 | 2019 | 141 | 1.110 |
Why?
|
Barrett Esophagus | 2 | 2020 | 494 | 1.100 |
Why?
|
Hepatitis B, Chronic | 3 | 2017 | 393 | 0.940 |
Why?
|
Alagille Syndrome | 2 | 2022 | 35 | 0.930 |
Why?
|
Dyskeratosis Congenita | 1 | 2023 | 72 | 0.870 |
Why?
|
Gastric Mucosa | 3 | 2021 | 598 | 0.830 |
Why?
|
Basal Cell Nevus Syndrome | 1 | 2022 | 40 | 0.820 |
Why?
|
Esophagus | 2 | 2019 | 1017 | 0.810 |
Why?
|
Tongue Diseases | 1 | 2021 | 67 | 0.770 |
Why?
|
Skin Diseases | 2 | 2022 | 1065 | 0.770 |
Why?
|
Hemangiosarcoma | 1 | 2023 | 236 | 0.760 |
Why?
|
Choledochal Cyst | 1 | 2020 | 25 | 0.750 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1027 | 0.740 |
Why?
|
Liver Failure, Acute | 1 | 2022 | 165 | 0.740 |
Why?
|
Histiocytoma, Malignant Fibrous | 1 | 2020 | 63 | 0.730 |
Why?
|
Biopsy | 10 | 2022 | 6756 | 0.710 |
Why?
|
Co-Repressor Proteins | 1 | 2020 | 194 | 0.710 |
Why?
|
Colon, Transverse | 1 | 2019 | 23 | 0.710 |
Why?
|
Lymphocytes | 2 | 2019 | 2614 | 0.700 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2019 | 50 | 0.700 |
Why?
|
Bladder Exstrophy | 1 | 2020 | 106 | 0.690 |
Why?
|
Duodenitis | 1 | 2019 | 18 | 0.690 |
Why?
|
Gingival Neoplasms | 1 | 2019 | 21 | 0.690 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2019 | 42 | 0.690 |
Why?
|
Neoplasms, Adipose Tissue | 1 | 2019 | 15 | 0.690 |
Why?
|
Bronchoalveolar Lavage | 1 | 2019 | 120 | 0.680 |
Why?
|
Polyps | 1 | 2020 | 189 | 0.680 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 48 | 0.670 |
Why?
|
Intestinal Atresia | 1 | 2019 | 68 | 0.670 |
Why?
|
Colitis, Ulcerative | 3 | 2021 | 1901 | 0.670 |
Why?
|
Jejunal Diseases | 1 | 2019 | 50 | 0.670 |
Why?
|
Awards and Prizes | 1 | 2023 | 375 | 0.630 |
Why?
|
Diagnosis, Differential | 12 | 2022 | 12958 | 0.630 |
Why?
|
Inflammatory Bowel Diseases | 4 | 2023 | 2410 | 0.610 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2019 | 301 | 0.610 |
Why?
|
Liver Transplantation | 4 | 2022 | 2117 | 0.590 |
Why?
|
Granuloma, Pyogenic | 1 | 2017 | 48 | 0.580 |
Why?
|
Jejunum | 1 | 2019 | 480 | 0.580 |
Why?
|
Submandibular Gland Diseases | 1 | 2016 | 21 | 0.570 |
Why?
|
Neck | 1 | 2021 | 693 | 0.560 |
Why?
|
Hemangioendothelioma | 1 | 2017 | 121 | 0.560 |
Why?
|
Antiviral Agents | 2 | 2019 | 2978 | 0.560 |
Why?
|
Esophageal Motility Disorders | 1 | 2016 | 44 | 0.550 |
Why?
|
Histiocytes | 1 | 2016 | 103 | 0.550 |
Why?
|
Sialadenitis | 1 | 2016 | 43 | 0.550 |
Why?
|
Candidiasis | 1 | 2019 | 365 | 0.550 |
Why?
|
Pigmentation | 1 | 2016 | 148 | 0.550 |
Why?
|
Cysts | 1 | 2021 | 676 | 0.540 |
Why?
|
Liver Diseases | 3 | 2022 | 1252 | 0.540 |
Why?
|
Budd-Chiari Syndrome | 1 | 2015 | 25 | 0.530 |
Why?
|
Bile Ducts, Extrahepatic | 1 | 2015 | 49 | 0.530 |
Why?
|
Vascular Malformations | 1 | 2021 | 450 | 0.520 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2015 | 32 | 0.520 |
Why?
|
Head | 1 | 2021 | 878 | 0.520 |
Why?
|
Colonoscopy | 2 | 2021 | 1365 | 0.520 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2014 | 21 | 0.510 |
Why?
|
Metaplasia | 3 | 2020 | 313 | 0.500 |
Why?
|
Colonic Polyps | 1 | 2019 | 542 | 0.490 |
Why?
|
Adenovirus Infections, Human | 1 | 2014 | 71 | 0.480 |
Why?
|
Hepatitis, Viral, Human | 1 | 2014 | 138 | 0.480 |
Why?
|
Child | 24 | 2023 | 77478 | 0.480 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 814 | 0.480 |
Why?
|
Sarcoma, Kaposi | 1 | 2017 | 370 | 0.470 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2015 | 295 | 0.470 |
Why?
|
Polycythemia Vera | 1 | 2015 | 163 | 0.460 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 782 | 0.440 |
Why?
|
Biliary Atresia | 1 | 2022 | 72 | 0.410 |
Why?
|
Varicose Veins | 1 | 2022 | 154 | 0.370 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2020 | 68 | 0.370 |
Why?
|
Esophageal and Gastric Varices | 1 | 2022 | 207 | 0.360 |
Why?
|
Bile Duct Neoplasms | 1 | 2015 | 567 | 0.360 |
Why?
|
Cholangiocarcinoma | 1 | 2015 | 516 | 0.360 |
Why?
|
Humans | 63 | 2023 | 742088 | 0.360 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2020 | 107 | 0.350 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2015 | 484 | 0.350 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 2 | 2020 | 147 | 0.350 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 2940 | 0.340 |
Why?
|
Immunocompromised Host | 1 | 2014 | 847 | 0.340 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3585 | 0.320 |
Why?
|
Esophagogastric Junction | 2 | 2020 | 312 | 0.320 |
Why?
|
Chromosome Aberrations | 1 | 2015 | 1811 | 0.320 |
Why?
|
Bone and Bones | 1 | 2018 | 2575 | 0.300 |
Why?
|
Male | 36 | 2022 | 349538 | 0.300 |
Why?
|
Endothelial Cells | 3 | 2023 | 3455 | 0.280 |
Why?
|
beta Catenin | 3 | 2020 | 1058 | 0.270 |
Why?
|
Adolescent | 16 | 2022 | 85649 | 0.270 |
Why?
|
Female | 35 | 2021 | 379592 | 0.250 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4554 | 0.240 |
Why?
|
Prognosis | 8 | 2022 | 29010 | 0.240 |
Why?
|
Mevalonate Kinase Deficiency | 1 | 2023 | 19 | 0.230 |
Why?
|
Infant | 9 | 2022 | 35070 | 0.230 |
Why?
|
Sweet Syndrome | 1 | 2023 | 47 | 0.230 |
Why?
|
Skin | 1 | 2017 | 4353 | 0.230 |
Why?
|
Lymphangioma | 1 | 2023 | 65 | 0.230 |
Why?
|
Sarcoma | 1 | 2015 | 1895 | 0.230 |
Why?
|
Leukoplakia, Oral | 1 | 2023 | 73 | 0.220 |
Why?
|
Horner Syndrome | 1 | 2022 | 37 | 0.210 |
Why?
|
Dystrophin | 1 | 2023 | 285 | 0.210 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2021 | 45 | 0.200 |
Why?
|
Activating Transcription Factor 1 | 1 | 2020 | 26 | 0.190 |
Why?
|
Sarcoma, Clear Cell | 1 | 2021 | 76 | 0.190 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2023 | 256 | 0.190 |
Why?
|
Immunohistochemistry | 4 | 2020 | 11363 | 0.190 |
Why?
|
Tandem Repeat Sequences | 1 | 2021 | 185 | 0.190 |
Why?
|
Esophageal Achalasia | 1 | 2021 | 91 | 0.180 |
Why?
|
Transgenes | 1 | 2023 | 1009 | 0.180 |
Why?
|
Duodenal Diseases | 1 | 2020 | 102 | 0.180 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2020 | 104 | 0.180 |
Why?
|
Umbilical Cord | 1 | 2021 | 180 | 0.180 |
Why?
|
Lymphocytosis | 1 | 2020 | 119 | 0.170 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2020 | 101 | 0.170 |
Why?
|
Cholestasis | 1 | 2022 | 378 | 0.170 |
Why?
|
Pathology, Surgical | 1 | 2020 | 155 | 0.170 |
Why?
|
Infant, Newborn | 5 | 2023 | 25575 | 0.170 |
Why?
|
Scalp | 1 | 2022 | 380 | 0.170 |
Why?
|
RNA-Binding Protein EWS | 1 | 2020 | 216 | 0.170 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9410 | 0.170 |
Why?
|
Fetal Death | 1 | 2021 | 447 | 0.170 |
Why?
|
Middle Aged | 18 | 2021 | 213127 | 0.170 |
Why?
|
Gallbladder | 1 | 2020 | 301 | 0.170 |
Why?
|
Spores, Fungal | 1 | 2019 | 94 | 0.170 |
Why?
|
Chromogranins | 1 | 2019 | 163 | 0.170 |
Why?
|
Th1 Cells | 2 | 2021 | 1056 | 0.160 |
Why?
|
Tongue | 1 | 2021 | 406 | 0.160 |
Why?
|
Cholangitis, Sclerosing | 1 | 2020 | 159 | 0.160 |
Why?
|
Candida | 1 | 2019 | 172 | 0.160 |
Why?
|
Intestinal Mucosa | 2 | 2019 | 3038 | 0.150 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2020 | 514 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 2 | 2021 | 4553 | 0.150 |
Why?
|
Elasticity Imaging Techniques | 1 | 2022 | 388 | 0.150 |
Why?
|
Uridine Monophosphate | 1 | 2018 | 69 | 0.150 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2019 | 202 | 0.150 |
Why?
|
Gene Fusion | 1 | 2020 | 371 | 0.150 |
Why?
|
Child, Preschool | 6 | 2022 | 40955 | 0.150 |
Why?
|
Esophagoscopy | 1 | 2019 | 390 | 0.150 |
Why?
|
Spleen | 1 | 2023 | 2359 | 0.150 |
Why?
|
Fluorenes | 1 | 2018 | 159 | 0.140 |
Why?
|
Epithelium | 1 | 2021 | 1680 | 0.140 |
Why?
|
Maxilla | 1 | 2019 | 469 | 0.140 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2022 | 642 | 0.140 |
Why?
|
Ribavirin | 1 | 2018 | 395 | 0.140 |
Why?
|
Retrospective Studies | 12 | 2023 | 77098 | 0.140 |
Why?
|
Eosinophilia | 1 | 2020 | 531 | 0.140 |
Why?
|
Malacoplakia | 1 | 2015 | 15 | 0.130 |
Why?
|
Transaminases | 1 | 2016 | 199 | 0.130 |
Why?
|
Histology | 1 | 2015 | 16 | 0.130 |
Why?
|
Hedgehog Proteins | 1 | 2020 | 781 | 0.130 |
Why?
|
Hepatectomy | 1 | 2019 | 550 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 409 | 0.130 |
Why?
|
Aged | 12 | 2021 | 162944 | 0.120 |
Why?
|
Telomerase | 1 | 2019 | 729 | 0.120 |
Why?
|
Lymphocyte Count | 1 | 2016 | 792 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1225 | 0.120 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1606 | 0.120 |
Why?
|
Pancreas | 1 | 2020 | 1684 | 0.110 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2017 | 644 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2011 | 0.110 |
Why?
|
Paraneoplastic Syndromes | 1 | 2014 | 150 | 0.110 |
Why?
|
Gene Silencing | 1 | 2019 | 1538 | 0.110 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2019 | 859 | 0.110 |
Why?
|
Europe | 1 | 2019 | 3339 | 0.110 |
Why?
|
Adult | 13 | 2023 | 213712 | 0.110 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13655 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 848 | 0.110 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15056 | 0.100 |
Why?
|
Hemangioma | 1 | 2017 | 737 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2020 | 1167 | 0.100 |
Why?
|
Soft Tissue Neoplasms | 1 | 2021 | 1361 | 0.100 |
Why?
|
Diet, Reducing | 1 | 2014 | 461 | 0.100 |
Why?
|
Mutation | 4 | 2020 | 29717 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39004 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2021 | 3020 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1184 | 0.090 |
Why?
|
Preoperative Care | 1 | 2019 | 2245 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2906 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4751 | 0.080 |
Why?
|
Patient Selection | 1 | 2019 | 4214 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2736 | 0.070 |
Why?
|
Disease Progression | 2 | 2020 | 13256 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15530 | 0.070 |
Why?
|
Autoimmunity | 1 | 2014 | 1348 | 0.070 |
Why?
|
Inflammation | 2 | 2018 | 10578 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3711 | 0.070 |
Why?
|
Rectal Neoplasms | 1 | 2015 | 1195 | 0.070 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3328 | 0.070 |
Why?
|
Sex Factors | 1 | 2019 | 10392 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4229 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1130 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2019 | 5851 | 0.060 |
Why?
|
Prevalence | 2 | 2021 | 15194 | 0.060 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2721 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2014 | 1631 | 0.060 |
Why?
|
Age Factors | 1 | 2020 | 18355 | 0.060 |
Why?
|
Weight Loss | 1 | 2014 | 2604 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2020 | 6347 | 0.060 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 58 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8621 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13403 | 0.050 |
Why?
|
Single Umbilical Artery | 1 | 2021 | 3 | 0.050 |
Why?
|
Risk Factors | 2 | 2020 | 72145 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 35342 | 0.050 |
Why?
|
Diet | 1 | 2019 | 7923 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2015 | 13029 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 8829 | 0.040 |
Why?
|
Blood Glucose | 1 | 2014 | 6249 | 0.040 |
Why?
|
Obesity | 1 | 2022 | 12705 | 0.040 |
Why?
|
Interleukin-8 | 1 | 2022 | 689 | 0.040 |
Why?
|
Codon | 1 | 2021 | 611 | 0.040 |
Why?
|
Young Adult | 2 | 2020 | 56350 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 21719 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2023 | 1849 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2020 | 528 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7873 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 890 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2017 | 5662 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2019 | 62966 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2015 | 10163 | 0.040 |
Why?
|
Immune Tolerance | 2 | 2017 | 2257 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2014 | 5249 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1676 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5724 | 0.030 |
Why?
|
Observer Variation | 1 | 2021 | 2593 | 0.030 |
Why?
|
Oncogenes | 1 | 2021 | 1263 | 0.030 |
Why?
|
Exons | 1 | 2021 | 2431 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2459 | 0.030 |
Why?
|
Thiazoles | 1 | 2022 | 1484 | 0.030 |
Why?
|
United States | 2 | 2019 | 69693 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57683 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13921 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2015 | 5519 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19862 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17400 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 9185 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8425 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2022 | 1864 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1866 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2017 | 712 | 0.030 |
Why?
|
Animals | 4 | 2017 | 168561 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2023 | 2956 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1038 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20086 | 0.020 |
Why?
|
Taxoids | 1 | 2014 | 665 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21596 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2014 | 640 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1589 | 0.020 |
Why?
|
Deoxycytidine | 1 | 2014 | 824 | 0.020 |
Why?
|
Chemokines | 1 | 2014 | 954 | 0.020 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2014 | 571 | 0.020 |
Why?
|
Pancreatectomy | 1 | 2014 | 802 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1274 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2015 | 14554 | 0.020 |
Why?
|
Antigens | 1 | 2015 | 1462 | 0.020 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 834 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.020 |
Why?
|
Tumor Burden | 1 | 2014 | 1905 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4379 | 0.020 |
Why?
|
Fasting | 1 | 2014 | 1589 | 0.020 |
Why?
|
Th17 Cells | 1 | 2014 | 765 | 0.020 |
Why?
|
Ligands | 1 | 2015 | 3293 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3444 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2026 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2022 | 11001 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2023 | 10472 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2014 | 1780 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 21821 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 53187 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6382 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2014 | 2066 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2017 | 3564 | 0.020 |
Why?
|
Acute Disease | 1 | 2014 | 7141 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2014 | 5975 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14720 | 0.010 |
Why?
|
DNA Methylation | 1 | 2017 | 4282 | 0.010 |
Why?
|
Signal Transduction | 2 | 2017 | 23387 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2015 | 9735 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2130 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12695 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 24913 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 20928 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29087 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.010 |
Why?
|
Mice | 2 | 2015 | 81045 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40054 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16331 | 0.010 |
Why?
|
Aging | 1 | 2014 | 8626 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11472 | 0.010 |
Why?
|